Youla S. Tsantrizos

Youla S. Tsantrizos


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2019 in Critical Reviews in Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
DWDaniel D. Waller
Daniel D. Waller
JPJaeok Park
Jaeok Park
Youla S. TsantrizosYoula S. Tsantrizos
Youla S. Tsantrizos
Dysregulation of isoprenoid biosynthesis is implicated in numerous biochemical disorders that play a role in the onset and/or progression of age-related diseases, such as hypercholesterolemia, osteoporosis, various cancers, and neurodegeneration. The mevalonate metabolic pathway is responsible for the biosynthesis of the two key isoprenoid metabolites, farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP). Post-translational prenylation of various proteins, including the small GTP-binding proteins (GTPases), with either FPP or GGPP is vital for proper localization and activation of these proteins. Prenylated GTPases play a critical role in cell signaling, proliferation, cellular plasticity, oncogenesis, and cancer metastasis. Pre-clinical and clinical studies strongly suggest that inhibition of protein prenylation can be an effective treatment for non-skeletal cancers. In this review, we summarize the most recent drug discovery efforts focusing on blocking protein farnesylation and/or geranylgeranylation and the biochemical and structural data available in guiding the current on-going studies in drug discovery. Furthermore, we provide a summary on the biochemical association between disruption of protein prenylation, endoplasmic reticulum (ER) stress, unfolded protein response (UPR) signaling, and cancer.

22 July 2014 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
JPJaeok Park
Jaeok Park
AMAlexios N. Matralis
Alexios N. Matralis
ABAlbert M. Berghuis
Albert M. Berghuis
Youla S. TsantrizosYoula S. Tsantrizos
Youla S. Tsantrizos
The complex biochemical network known as the mevalonate pathway is responsible for the biosynthesis of all isoprenoids in the human body, which consists of a vast array of metabolites that are vital for proper cellular functions. Two key isoprenoids, farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) are responsible for the post-translational prenylation of small GTP-binding proteins, and serve as the biosynthetic precursors to numerous other biomolecules. The down-stream metabolite of FPP and GGPP is squalene, the precursor to steroids, bile acids, lipoproteins and vitamin D. In the past, interest in prenyl synthase inhibitors focused mainly on the role of the FPP in lytic bone diseases. More recently, pre-clinical and clinical studies have strongly implicated high levels of protein prenylation in a plethora of human diseases, including non-skeletal cancers, the progression of neurodegenerative diseases and cardiovascular diseases. In this review, we focus mainly on the potential therapeutic value of down-regulating the biosynthesis of FPP, GGPP and squalene. We summarize the most recent drug discovery efforts and the structural data available that support the current on-going studies.

3 October 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CLChun Yuen Leung
Chun Yuen Leung
JPJaeok Park
Jaeok Park
JSJoris W. De Schutter
Joris W. De Schutter
MSMichael Sebag
Michael Sebag
ABAlbert M. Berghuis
Albert M. Berghuis
Youla S. TsantrizosYoula S. Tsantrizos
Youla S. Tsantrizos

17 July 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CLCyrus M. Lacbay
Cyrus M. Lacbay
DWDaniel D. Waller
Daniel D. Waller
JPJaeok Park
Jaeok Park
MPMònica Gómez Palou
Mònica Gómez Palou
FVFélix Vincent
Félix Vincent
Youla S. TsantrizosYoula S. Tsantrizos
Youla S. Tsantrizos

29 August 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CLCyrus M. Lacbay
Cyrus M. Lacbay
JMJohn Mancuso
John Mancuso
YLYih-Shyan Lin
Yih-Shyan Lin
NBNicholas Bennett
Nicholas Bennett
MGMatthias Götte
Matthias Götte
Youla S. TsantrizosYoula S. Tsantrizos
Youla S. Tsantrizos

23 June 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JSJoris W. De Schutter
Joris W. De Schutter
JPJaeok Park
Jaeok Park
CLChun Yuen Leung
Chun Yuen Leung
PGPatrick Gormley
Patrick Gormley
YLYih-Shyan Lin
Yih-Shyan Lin
Youla S. TsantrizosYoula S. Tsantrizos
Youla S. Tsantrizos